SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Library > White / Technical Paper

Identifying the Product

Published: 06-Feb-2013 | Format: PDF file | Document type: White / Technical Paper

When it comes to developing a compound, the 505(b)(2) pathway can make changes to reference products for greater profit potential and lower risk.

 

Camargo Pharmaceutical Services offers a clear process from concept through commercialization to identify products with documented market differentiation:

  • Selection criteria
  • Identify, assess and rank unmet needs
  • Defend value and maximize investment
  • Narrow candidates
  • 505(b)(2) development plan
  • Product case histories

 

For differentiated product benefits, 505(b)(2) is not just a regulatory platform — it’s a different animal.

Supplier's Info Centre